Skinner; Philip J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skinner; Philip J..The latest application filed is for "3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders".

Company Profile

0.6.8

Skinner; Philip J. - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof Grant 8,637,555 - Semple , et al. January 28, 2	2014-01-28
3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders Grant 8,507,473 - Boatman , et al. August 13, 2	2013-08-13
3h-imidazo[4,5-b]pyridin-5-ol Derivatives Useful In The Treatment Of Gpr81 Receptor Disorders App 20110172209 - Boatman; P. Douglas ; et al.	2011-07-14
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof Grant 7,612,106 - Boatman , et al. November 3, 2	2009-11-03
Fused Pyrazole Derivatives And Methods Of Treatment Of Metabolic-related Disorders Thereof App 20090258892 - Boatman; P. Douglas ; et al.	2009-10-15
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof Grant 7,241,792 - Boatman , et al. July 10, 2	2007-07-10
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof App 20070072924 - Semple; Graeme ; et al.	2007-03-29
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof App 20070073062 - Boatman; P. Douglas ; et al.	2007-03-29
5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases App 20070032537 - Semple; Graeme ; et al.	2007-02-08
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof App 20060205955 - Boatman; P. Douglas ; et al.	2006-09-14
5-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia App 20060167270 - Semple; Graeme ; et al.	2006-07-27
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof App 20060122240 - Semple; Graeme ; et al.	2006-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.